The use of fluticasone furoate-vilanterol inhalers is tied to slightly better clinical outcomes than the use of budesonide-formoterol or fluticasone propionate-salmeterol inhalers in new COPD users.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/fluticasone-vilanterol-copd-fewer-puffs-slight-benefit-2026a10008fh?src=rss
Author :
Publish date : 2026-03-19 12:30:00
Copyright for syndicated content belongs to the linked Source.
